Fingerprint
Dive into the research topics of 'A multicenter, open-label long-term safety study of rimegepant for the acute treatment of migraine'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A multicenter, open-label long-term safety study of rimegepant for the acute treatment of migraine
Robert Croop, Gary Berman, David Kudrow, Kathleen Mullin, Alexandra Thiry, Meghan Lovegren, Gilbert L’Italien, Richard B. Lipton
Research output: Contribution to journal › Article › peer-review
28
Scopus
citations